US Patent 7422861 Oligonucleotide transfection screening method
Patent 7422861 was granted and assigned to Novartis on September, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+317 characters)
Article
Patent abstract
Different-sequence peptoids, including lipid- and sterol-conjugated peptoids, are found to be effective in transfection of cells with oligonucleotides. Combinatorial libraries of such peptoids can be screened efficiently in a high-throughput format, and selected peptoids are identified post-screening.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07422861 Oligonucleotide transfection screening method US Patent 7422861 Oligonucleotide transfection screening method
Infobox
Patent Number
0742286100
Patent Number
742286100
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074228610
Date of Patent
September 9, 2008
0Patent Application Number
100254230
Date Filed
December 18, 2001
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074228610
Date of Patent
September 9, 2008
0Patent Application Number
100254230
Date Filed
December 18, 2001
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07422861 Oligonucleotide transfection screening method
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07422861
Date of patent
September 9, 2008
Patent application number
10025423
Date Filed
December 18, 2001
Patent primary examiner
Find more entities like US Patent 7422861 Oligonucleotide transfection screening method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
